‘In A Word, Complicated’ – AAM’s Burton Talks US Biosimilars

Biosimilars Council Chief Sees Improvement In US Market, But Says There Is Further To Go

 
• By David Wallace
  
A line in a tangled mess, complicated concept
Craig Burton explains the complications of the US biosimilars market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products